Evolution of interfacial mechanics of lung surfactant mimics progression of acute respiratory distress syndrome

被引:4
|
作者
Ciutara, Clara O. [1 ]
V. Iasella, Steven [1 ]
Huang, Boxun [1 ]
Barman, Sourav [1 ]
Zasadzinski, Joseph A. [1 ]
机构
[1] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA
关键词
lysolipids; phospholipids; acute respiratory distress syndrome; dilatational rheology; Laplace instability; PULMONARY SURFACTANT; COMPETITIVE ADSORPTION; DETERGENT SOLUBILIZATION; HYDROPHILIC POLYMERS; LANGMUIR MONOLAYERS; INHIBITION; INACTIVATION; REFLECTIVITY; PENETRATION; COEXISTENCE;
D O I
10.1073/pnas.2309900120
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
How acute respiratory distress syndrome progresses from underlying disease or trauma is poorly understood, and there are no generally accepted treatments resulting in a 40% mortality rate. However, during the inflammation that accompanies this disease, the phospholipase A(2) concentration increases in the alveolar fluids leading to the hydrolysis of bacterial, viral, and lung surfactant phospholipids into soluble lysolipids. We show that if the lysolipid concentration in the subphase reaches or exceeds its critical micelle concentration, the surface tension, gamma, of dipalmitoyl phosphatidylcholine (DPPC) or Curosurf monolayers increases and the dilatational modulus, E*(omega), decreases to that of a pure lysolipid interface. This is consistent with DPPC being solubilized in lyso-lipid micelles and being replaced by lysolipid at the interface. These changes lead to 2E* - gamma < 0, which is the criterion for the Laplace instability that can lead to mechanical instabilities during lung inflation, potentially causing alveolar collapse. These findings provide a mechanism behind the alveolar collapse and uneven lung inflation during ARDS.
引用
下载
收藏
页数:11
相关论文
共 50 条
  • [1] Respiratory mechanics and surfactant in the acute respiratory distress syndrome
    Bersten, AD
    Davidson, K
    Nicholas, TE
    Doyle, IR
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (11) : 955 - 963
  • [2] Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
    Koumbourlis, Anastassios C.
    Motoyama, Etsuro K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (04) : 624 - 626
  • [3] Acute respiratory distress syndrome mimics: the role of lung biopsy
    Aublanc, Mylene
    Perinel, Sophie
    Guerin, Claude
    CURRENT OPINION IN CRITICAL CARE, 2017, 23 (01) : 24 - 29
  • [4] Mimics of Acute Respiratory Distress Syndrome
    Patel, Kaushal
    Baltaji, Stephanie
    Rabold, Erica
    Malik, Khalid
    Adurty, Rajashekar
    Cheema, Tariq
    CRITICAL CARE NURSING QUARTERLY, 2019, 42 (04) : 417 - 430
  • [5] Surfactant Therapy for Acute Lung Injury and Acute Respiratory Distress Syndrome
    Raghavendran, Krishnan
    Willson, D.
    Notter, R. N.
    CRITICAL CARE CLINICS, 2011, 27 (03) : 525 - +
  • [6] Surfactant for acute respiratory distress syndrome
    Jobe, AH
    Ikegami, M
    ADVANCES IN INTERNAL MEDICINE, VOL 42, 1997, 42 : 203 - 230
  • [7] Respiratory mechanics and lung stress/strain in children with acute respiratory distress syndrome
    Davide Chiumello
    Giovanna Chidini
    Edoardo Calderini
    Andrea Colombo
    Francesco Crimella
    Matteo Brioni
    Annals of Intensive Care, 6
  • [8] Respiratory mechanics and lung stress/strain in children with acute respiratory distress syndrome
    Chiumello, Davide
    Chidini, Giovanna
    Calderini, Edoardo
    Colombo, Andrea
    Crimella, Francesco
    Brioni, Matteo
    ANNALS OF INTENSIVE CARE, 2016, 6 : 1 - 9
  • [9] Surfactant therapy in adults with acute lung injury/acute respiratory distress syndrome
    Kesecioglu, J
    Haitsma, JJ
    CURRENT OPINION IN CRITICAL CARE, 2006, 12 (01) : 55 - 60
  • [10] Exogenous Surfactant in Paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome
    Playfor, Stephen D.
    Nootigattu, Venkata K. T.
    CURRENT DRUG SAFETY, 2006, 1 (02) : 159 - 168